GE HealthCare (Nasdaq: GEHC) has introduced SIGNA MAGNUS, a head-only magnetic resonance (MR) scanner awaiting FDA 510(k) approval. This cutting-edge technology aims to revolutionize neuroscience research, addressing the limitations of conventional whole-body MR systems. Despite significant advancements, neuroscience, particularly in…
Teacher Appreciation Week arrives annually during the first full week of May, serving as a dedicated time to recognize and celebrate the unwavering commitment of educators worldwide. It presents an invaluable opportunity to express gratitude for the tireless efforts of…
Biogen Inc. (Nasdaq: BIIB) has released its 2023 Corporate Responsibility Report, illustrating the company’s strides in adhering to ethical business practices for the betterment of all stakeholders. Christopher A. Viehbacher, President and CEO of Biogen, expressed pride in the company’s…
CVS Health Corporation (NYSE: CVS) unveiled its financial performance for the first quarter ending March 31, 2024, showcasing robust revenue growth alongside strategic adjustments to its annual guidance. First Quarter Highlights: 2024 Full-Year Guidance Revisions: CEO Commentary: Karen S. Lynch,…
AbbVie Initiates Construction of State-of-the-Art Research Hub, “LUnA,” in Germany with €150 Million Investment AbbVie has commenced the construction of its new central research building, dubbed “LUnA” (LUdwighafens neue Arbeitswelt), solidifying its commitment with approximately €150 million investment in its…
Recognizing the Stealthy Signs of Bladder Cancer Identifying bladder cancer in its early stages can be challenging, as its symptoms often mimic those of benign conditions like urinary tract infections or kidney stones. However, the presence of blood in the…
In today’s fast-paced world, the essence of healthcare often gets lost in the shuffle. Johnson & Johnson, however, is on a mission to redefine the meaning behind two fundamental words: Health & Care. Their aim is to fuse cutting-edge innovations…
Bio-Techne Corporation (NASDAQ: TECH) and Novomol-Dx, a pioneering molecular diagnostics firm, proudly introduce the Bio-Marker Pathfinder (BMP), a groundbreaking ocular biomarker kit designed for point-of-care application. Novomol-Dx specializes in commercializing tests for diagnosing and treating ophthalmic diseases, leveraging biomarkers discovered…
Shionogi & Co., Ltd. (Headquartered in Osaka, Japan; CEO: Isao Teshirogi, Ph.D.; hereafter referred to as “Shionogi”) has announced revisions to its dividend forecasts for the fiscal year ending March 31, 2024 (fiscal 2023; April 1, 2023 – March 31,…
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a prominent global oncology firm, has unveiled its 2023 Responsible Business & Sustainability Report, spotlighting the company’s strategic direction, progress towards existing objectives, and its vision for achieving ambitious new targets. This…
Bayer Group’s divisions demonstrated resilience and strength in several core areas, surpassing industry peers, according to CEO Bill Anderson during the virtual Annual Stockholders’ Meeting. Anderson praised the progress in cancer and Parkinson’s disease drug research, herbicide development, and bolstering…
Biogen Inc. (Nasdaq: BIIB) has announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a favorable opinion for TOFIDENCE™ (tocilizumab), a biosimilar monoclonal antibody referencing ROACTEMRA®1. The intravenous formulation…
